Arcadia Biosciences, Inc. (RKDA)
3.0400 +0.03 (1.00%)
After hours: 4:35PM EST
Chart Events
Performance Outlook
| Previous Close | 3.4500 |
| Open | 3.0000 |
| Bid | 2.9700 x 21500 |
| Ask | 2.9700 x 4000 |
| Day's Range | 2.9100 - 3.0500 |
| 52 Week Range | 2.3000 - 6.4800 |
| Volume | 3,287,961 |
| Avg. Volume | 380,339 |
| Market Cap | 40.487M |
| Beta (5Y Monthly) | -0.63 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.1230 |
| Earnings Date | Nov 12, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.67 |
- PR Newswire
Arcadia Biosciences (RKDA) Announces $25.1 Million Private Placement
Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced that it has entered into definitive agreements with several institutional and other accredited investors for the purchase of 7,876,784 shares of its common stock at a purchase price per share of $3.1925, in a private placement priced at-the-market under Nasdaq rules. Additionally, Arcadia has also agreed to issue to the investors warrants to purchase up to 3,938,392 shares of common stock. The warrants to purchase 3,938,392 shares of common stock have an exercise price of $3.13 per share, will be immediately exercisable and will expire five and one-half years from the issue date. The closing of the offering is expected to occur on or about January 27, 2021, subject to the satisfaction of customary closing conditions.
- PR Newswire
Arcadia Biosciences (RKDA) Announces Closing of $8.0 Million Registered Direct Offering Priced At-the-Market
Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced the closing of its previously announced registered direct offering of 2,618,658 shares of its common stock. The offering was priced at-the-market at a purchase price per share of $2.93, for gross proceeds of approximately $7.7 million. Additionally, in a concurrent private placement, Arcadia issued unregistered warrants to purchase up to 2,618,658 shares of common stock, representing 100 percent of the shares of common stock purchased in the registered direct offering. Each warrant was sold at a price of $0.125 per underlying warrant share for gross proceeds of approximately $327,000. Each warrant has an exercise price of $3.00 per share, is exercisable immediately and will expire five and one-half years from the issuance date.
- PR Newswire
Arcadia Biosciences (RKDA) Announces $8.0 Million Registered Direct Offering Priced At-the-Market
Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced that it has entered into definitive agreements with several institutional and other accredited investors for the purchase of 2,618,658 shares of its common stock, at a purchase price per share of $3.055, in a registered direct offering priced at-the-market under Nasdaq rules. Additionally, Arcadia has also agreed to issue to the investors unregistered warrants to purchase up to 2,618,658 shares of common stock. The closing of the offering is expected to occur on or about December 22, 2020, subject to the satisfaction of customary closing conditions.
